Full-Time
SaaS platform coordinating patient services
$175k - $210k/yr
New York, NY, USA
In Person
Courier Health provides a SaaS platform in biopharma that acts as an integrated command center to improve patient services. It coordinates patient touchpoints across marketing, patient services, and field reimbursement for large biopharma, specialty biotech, and rare disease organizations. The platform consolidates data into a single system of record, enabling real-time coordination, automated scheduling, and AI-driven analytics to support personalized patient engagement. Its subscription-based model plus implementation and training services aims to streamline workflows and improve patient outcomes.
Company Size
51-200
Company Stage
Series B
Total Funding
$70.5M
Headquarters
New York City, New York
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
People at Courier Health who can refer or advise you
Health Insurance
Flexible PTO
Paid Parental Leave
Monthly healthy lifestyle stipend
Career coaching opportunities
Stock Options
Equity
Courier Health launches first-ever Patient Innovators Awards PR newswire NEW YORK, Aug. 19, 2025.
Courier Health announced a $16.5 million Series A led by Norwest Venture Partners with participation from existing investor Work-Bench. The funding will support continued product innovation and hiring. Learn more.
The healthtech company plans to expand its engineering and sales organizations with the new funding.
- Courier Health, a technology company transforming patient experiences in the life sciences industry raises $16.5M in Series A funding led by Norwest Venture Partners with participation from existing investor Work-Bench.
Norwest Venture Partners-led financing helps meet growing demand for scalable patient engagement platformNEW YORK, July 9, 2024 /PRNewswire/ -- Courier Health , a technology company reimagining how life science manufacturers engage and support patients, today announced a $16.5 million Series A led by Norwest Venture Partners with participation from existing investor Work-Bench. The funding will support continued product innovation and hiring across engineering and sales to bring the company's purpose-built customer relationship management (CRM) platform to more biopharma partners in search of a comprehensive system for coordinating and personalizing the patient journey.Specialty medicines made up 93% of all drug approvals and the vast majority of R&D pipelines last year. Biopharma companies are building internal organizations to provide access, affordability and adherence support for these innovative therapies, yet they lack the specialized technology and data-driven visibility to coordinate efficiently across internal and external stakeholders."The number of specialty medicines has exploded over the last decade, forcing the evolution of commercial models to focus on the patient experience," said Danny Sigurdson, founder and CEO of Courier Health. "Unfortunately, the industry average remains that 60% to 70% of patients who are prescribed a specialty medicine either never start or discontinue within the first few months. We are thrilled to work with Norwest Venture Partners to advance our product innovation and add best-in-class talent to help more patients start and stay on these critically important medicines."Courier Health provides the only patient-based CRM platform developed specifically for biopharma field access, patient services and marketing teams to gain complete visibility and control over the end-to-end patient journey. The platform connects disparate data sets, enabling centralized patient and provider management, omnichannel workflow automation and advanced analytics—without the high cost of custom-built software